• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Molecular analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients.

作者信息

Lombardi M L, Mercuro O, Pirozzi G, Ionna F, Lombari V, Mozzillo N, Manzo C

机构信息

Oncologia Sperimentale C-Immunologia, Istituto Nazionale Tumori, Naples, Italy.

出版信息

J Immunother. 1998 Nov;21(6):435-9. doi: 10.1097/00002371-199811000-00005.

DOI:10.1097/00002371-199811000-00005
PMID:9807738
Abstract

Several studies have reported association between a variety of malignancies and human leukocyte antigens (HLA) genes. However, conflicting data have been reported on HLA association and melanoma. We report here serologic and molecular analysis by polymerase chain reaction sequence-specific primers (PCR-SSP) and PCR sequence-specific oligonucleotides (PCR-SSO) of HLA class II DRB1 and DQB1 loci in 132 patients with melanoma and 102 ethnically matched controls. Molecular typing of DQB1 polymorphism showed a significant increase of DQB1 0501 (25.0% versus 14.7%; p = 0.038). Moreover, an increase of DQB10301, which was present in 62.8% of patients and 54.9% of controls (p = 0.136), was noted. Because DQB10501 and DQB10301 are strongly linked to DRB101 and DRB111, respectively, both found increased in patients with melanoma, to look for a more stringent association with a particular allele specificity of the DR locus, we performed PCR-SSP high-resolution typing of DR1 and DR11 positive subjects. Results showed no significant difference between the frequencies of the alleles found in patients with respect to controls. Analysis of the distribution of DQB10501 and DQB10301 according to the AJCC clinical stage of the disease showed no significant difference in the frequency of these alleles between the localized and the metastatic form of the disease. However, none of the HLA class II alleles showed significant association after correction of the p value. These results indicate that HLA class II alleles may not contribute to a strong susceptibility to melanoma, at least in Italian patients.

摘要

相似文献

1
Molecular analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients.
J Immunother. 1998 Nov;21(6):435-9. doi: 10.1097/00002371-199811000-00005.
2
Molecular analysis of HLA-DRB1, -DQA1 and -DQB1 polymorphism in Turkey.土耳其人群中HLA-DRB1、-DQA1和-DQB1基因多态性的分子分析。
Tissue Antigens. 2000 Feb;55(2):171-4. doi: 10.1034/j.1399-0039.2000.550211.x.
3
Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population.意大利人群中DRB1*04 - DQB1*0301单倍型与CTLA - 4基因两个多态性位点与桥本甲状腺炎缺乏关联的研究
Thyroid. 2001 Feb;11(2):171-5. doi: 10.1089/105072501300042901.
4
HLA-DR and -DQ genotyping by PCR-SSO in Shanghai Chinese.在中国上海人群中采用聚合酶链反应-序列特异性寡核苷酸探针技术进行HLA-DR和-DQ基因分型
Tissue Antigens. 1993 May;41(5):223-6. doi: 10.1111/j.1399-0039.1993.tb02010.x.
5
HLA-DRB1, -DQB1 and -DPB1 polymorphism in the Slovak population.斯洛伐克人群中HLA - DRB1、- DQB1和 - DPB1基因多态性
Tissue Antigens. 1998 May;51(5):574-6. doi: 10.1111/j.1399-0039.1998.tb02996.x.
6
HLA-DR and -DQ alleles in Italian patients with melanoma.意大利黑色素瘤患者的HLA - DR和 - DQ等位基因
Tissue Antigens. 1998 Mar;51(3):276-80. doi: 10.1111/j.1399-0039.1998.tb03102.x.
7
HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.伊朗多发性硬化症(MS)患者中与人类白细胞抗原II类(DRB1、DQA1和DQB1)相关的遗传易感性
Eur J Immunogenet. 1998 Aug;25(4):297-301. doi: 10.1046/j.1365-2370.1998.00101.x.
8
Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population.伊朗正常人群中人类白细胞抗原II类等位基因频率及单倍型关联
Hum Immunol. 2001 Nov;62(11):1234-8. doi: 10.1016/s0198-8859(01)00320-2.
9
HLA class II DRB1, DQA1 and DQB1 polymorphisms in the Polish population from Wielkopolska.来自大波兰地区的波兰人群中HLA II类DRB1、DQA1和DQB1基因多态性
Tissue Antigens. 1997 Jun;49(6):624-8. doi: 10.1111/j.1399-0039.1997.tb02810.x.
10
HLA-DRB1, DQA1, DQB1 DNA polymorphism in the Bulgarian population.保加利亚人群中HLA - DRB1、DQA1、DQB1基因的DNA多态性
Tissue Antigens. 1996 Feb;47(2):122-6. doi: 10.1111/j.1399-0039.1996.tb02524.x.

引用本文的文献

1
HLA-DRB116:01 and HLA-DQB105:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma.HLA - DRB1 16:01和HLA - DQB1 05:02等位基因影响皮肤恶性黑色素瘤的易感性和进展。
J Oncol. 2021 Sep 30;2021:3801143. doi: 10.1155/2021/3801143. eCollection 2021.
2
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.全基因组关联荟萃分析结合多种风险表型为皮肤黑色素瘤易感性的遗传结构提供了新的见解。
Nat Genet. 2020 May;52(5):494-504. doi: 10.1038/s41588-020-0611-8. Epub 2020 Apr 27.
3
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
常见的斯堪的纳维亚人白细胞抗原祖传单倍型62.1作为晚期恶性黑色素瘤患者的预后因素。
Cancer Immunol Immunother. 2009 Oct;58(10):1599-608. doi: 10.1007/s00262-009-0669-8. Epub 2009 Feb 13.
4
Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.杀伤细胞免疫球蛋白样受体/人类白细胞抗原配体组合对恶性黑色素瘤免疫反应的影响
Cancer Immunol Immunother. 2007 Jan;56(1):95-100. doi: 10.1007/s00262-006-0151-9. Epub 2006 Mar 18.
5
HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.西班牙东南部皮肤恶性黑色素瘤患者中HLA I类和II类基因频率:HLA - C在疾病预后中的作用
Immunogenetics. 2006 Jan;57(12):926-33. doi: 10.1007/s00251-005-0065-2. Epub 2005 Dec 20.
6
Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama.阿拉巴马州中部患有皮肤黑色素瘤的白人成年人和对照受试者报告的血统。
BMC Cancer. 2004 Aug 13;4:47. doi: 10.1186/1471-2407-4-47.
7
Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.黑色素瘤患者中自然杀伤细胞受体及其配体的基因多态性:抑制性信号高于激活性信号的发生率
Cancer Immunol Immunother. 2005 Feb;54(2):172-8. doi: 10.1007/s00262-004-0575-z. Epub 2004 Jul 10.